---
figid: PMC11887407__12943_2025_2247_Fig4_HTML
figtitle: Oncogenic GNAS activation and downstream signal transduction
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11887407
filename: 12943_2025_2247_Fig4_HTML.jpg
figlink: /pmc/articles/PMC11887407/figure/F4/
number: F4
caption: Oncogenic GNAS activation and downstream signal transduction. The Gsp oncogene
  drives tumor progression through persistent activation of cAMP-PKA signaling. It
  activates the Hippo pathway, leading to tumor differentiation, promotes lipid metabolism
  via salt-inducible kinases (SIKs), and enhances tumor growth. It drives proliferation
  via the PKA-ERK1/2-MAPK axis and inflammation by activating the PKA-SRC-STAT3 pathway.
  It promotes tumorigenesis by inhibiting mitophagy and activating Wnt/β-catenin signaling.
  GNAS also acts as a tumor suppressor by negatively regulating the Shh signaling
  pathway. These pathways underscore the diverse roles of GNAS mutations in cancer
  progression
papertitle: 'Contract to kill: GNAS mutation'
reftext: Pratima Raut, et al. Mol Cancer. 2025;24(NA).
year: '2025'
doi: 10.1186/s12943-025-02247-4
journal_title: Molecular Cancer
journal_nlm_ta: Mol Cancer
publisher_name: BMC
keywords: GNAS | Gsα | GNAS R201 | Mutation | Tumor | Neoplasm
automl_pathway: 0.9563464
figid_alias: PMC11887407__F4
figtype: Figure
redirect_from: /figures/PMC11887407__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11887407__12943_2025_2247_Fig4_HTML.html
  '@type': Dataset
  description: Oncogenic GNAS activation and downstream signal transduction. The Gsp
    oncogene drives tumor progression through persistent activation of cAMP-PKA signaling.
    It activates the Hippo pathway, leading to tumor differentiation, promotes lipid
    metabolism via salt-inducible kinases (SIKs), and enhances tumor growth. It drives
    proliferation via the PKA-ERK1/2-MAPK axis and inflammation by activating the
    PKA-SRC-STAT3 pathway. It promotes tumorigenesis by inhibiting mitophagy and activating
    Wnt/β-catenin signaling. GNAS also acts as a tumor suppressor by negatively regulating
    the Shh signaling pathway. These pathways underscore the diverse roles of GNAS
    mutations in cancer progression
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AXIN1
  - AXIN2
  - CTNNB1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - APC
  - PROC
  - PTCH1
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - ATP8A2
  - SHH
  - SMO
  - SMOX
  - LATS1
  - SRC
  - FGR
  - FYN
  - YES1
  - SIK1
  - BNIP3L
  - SIK2
  - SIK3
  - MYC
  - BIRC5
  - HNF4A
  - YAP1
  - STAT3
  - MUC5AC
  - EPHB2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRTC1
  - CRTC2
  - CRTC3
  - TNFRSF9
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - GLI1
  - CCND1
  - Nucleus
  - ATP
  - CAMP
  - Protein
  - Shh
---
